BridgeMD
New treatment option for CABG
Official title Multimodal VR Rehabilitation for Cardiorespiratory Fitness in CABG Phase II
ClinicalTrials.gov ID: NCT07331558
What this study is testing
- What it's testing
- It will be a randomized clinical trial with a sample size of 66. A convenient sampling technique will be used to recruit the CABG phase II patients for the study.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 60
You may be able to join if
- Patients who underwent CABG surgery will be recruited after twelve weeks
- Both male and female
- Age 30-60 years old
- LVEF of \< 40%
- Persistent dyspnea with a self-rated intensity of ⩾5 (out of 10) on a visual analogue dyspnea scale (this dyspnea rating was only used as an...
You likely can't join if
- Patient with recurrent history of CABG
- Had a non-cardiac surgical procedure ≤2 months prior to recruitment
- Unstable angina, uncontrolled hypertension (blood pressure \>180/100 mmHg), a pacemaker or atrial fibrillation, documented peak orifice area valve...
- Documented chronic obstructive pulmonary disease (FEV1 \<60% and FVC \<60%)
- Any shoulder impairment that would limit exercise participation
- Patients with Kinesiophobia
See the full eligibility criteria
- Patients who underwent CABG surgery will be recruited after twelve weeks
- Both male and female
- Age 30-60 years old
- LVEF of \< 40%
- Persistent dyspnea with a self-rated intensity of ⩾5 (out of 10) on a visual analogue dyspnea scale (this dyspnea rating was only used as an inclusion criterion and not as a measure for outcome)
- Preserved cognitive function (Montreal Cognitive Assessment score \>24)
- Patient with recurrent history of CABG
- Had a non-cardiac surgical procedure ≤2 months prior to recruitment
- Unstable angina, uncontrolled hypertension (blood pressure \>180/100 mmHg), a pacemaker or atrial fibrillation, documented peak orifice area valve stenosis, symptomatic peripheral arterial disease that limits exercise...
- Documented chronic obstructive pulmonary disease (FEV1 \<60% and FVC \<60%)
- Any shoulder impairment that would limit exercise participation
- Patients with Kinesiophobia
- Epilepsy, vertigo, eyesight impairment (conditions contraindicated for VR)
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.